Caledonia Private Investments Pty Ltd Invests $4.14 Million in CME Group Inc. $CME

Caledonia Private Investments Pty Ltd acquired a new position in shares of CME Group Inc. (NASDAQ:CME - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 18,744 shares of the financial services provider's stock, valued at approximately $4,139,000. CME Group comprises 0.1% of Caledonia Private Investments Pty Ltd's portfolio, making the stock its 11th largest holding.

Other institutional investors also recently made changes to their positions in the company. BlackRock Inc. bought a new stake in shares of CME Group in the second quarter valued at about $6,749,965,000. Norges Bank acquired a new stake in CME Group in the 4th quarter worth about $1,523,241,000. Bank of New York Mellon Corp bought a new stake in CME Group in the 2nd quarter valued at about $867,313,000. Alphabet Inc. bought a new stake in CME Group in the 2nd quarter valued at about $769,376,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in shares of CME Group during the 2nd quarter worth approximately $629,771,000. Institutional investors own 87.75% of the company's stock.

Wall Street Analyst Weigh In

CME has been the subject of several recent research reports. Rothschild & Co Redburn upgraded CME Group from a "neutral" rating to a "buy" rating and boosted their price target for the company from $316.00 to $323.00 in a research note on Thursday, June 11th. Keefe, Bruyette & Woods upgraded CME Group from a "market perform" rating to an "outperform" rating and set a $305.00 price objective on the stock in a research note on Thursday, June 18th. Weiss Ratings cut CME Group from a "buy (b-)" rating to a "hold (c+)" rating in a report on Tuesday, August 11th. Piper Sandler cut their target price on CME Group from $329.00 to $295.00 and set an "overweight" rating for the company in a research report on Wednesday, July 15th. Finally, Erste Group Bank downgraded CME Group from a "buy" rating to a "hold" rating in a research note on Friday, June 5th. Nine analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $288.56.

CME Group Price Performance

Shares of NASDAQ:CME opened at $279.17 on Tuesday. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market cap of $100.38 billion, a price-to-earnings ratio of 23.68, a PEG ratio of 3.27 and a beta of 0.23. The firm has a 50 day simple moving average of $251.43 and a 200 day simple moving average of $279.47.

CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, topping analysts' consensus estimates of $2.91 by $0.08. The firm had revenue of $1.71 billion for the quarter, compared to analysts' expectations of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The company's revenue was up .8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.96 earnings per share. Research analysts predict that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be issued a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a dividend yield of 1.9%. The ex-dividend date is Wednesday, September 9th. CME Group's payout ratio is 44.11%.

Insider Activity

In other news, Director William R. Shepard acquired 325 shares of the stock in a transaction dated Thursday, June 25th. The stock was bought at an average price of $230.57 per share, with a total value of $74,935.25. Following the completion of the purchase, the director directly owned 260,442 shares of the company's stock, valued at $60,050,111.94. This represents a 0.12% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.30% of the stock is owned by corporate insiders.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source